We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $661M
1-Year Est. Return 50.59%
This Fund
S&P 500
This Quarter Est. Return
+6.04%
1 Year Est. Return
+50.59%
3 Year Est. Return
+135.47%
5 Year Est. Return
+202.82%
10 Year Est. Return
+1,069.65%
AUM
$509M
AUM Growth
+$18.7M
Cap. Flow
+$4.95M
Cap. Flow %
0.97%
Top 10 Hldgs %
15.43%
Holding
477
New
52
Increased
137
Reduced
129
Closed
42

Top Buys

Rank Stock Value
1
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$7.84M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$4.4M
3
ICUI icon
ICU Medical
ICUI
+$1.85M
4
MEDP icon
Medpace
MEDP
+$1.79M
5
LXFR icon
Luxfer Holdings
LXFR
+$1.73M

Top Sells

Rank Stock Value
1
AAMI
Acadian Asset Management
AAMI
+$7.07M
2
KMG
KMG Chemicals Inc
KMG
+$4.5M
3
TNET icon
TriNet
TNET
+$3.36M
4
EPI icon
WisdomTree India Earnings Fund ETF
EPI
+$2.47M
5
TBI
Trueblue
TBI
+$1.8M

Sector Composition

Rank Sector Weight
1 Healthcare 19.72%
2 Industrials 16.05%
3 Consumer Discretionary 14.61%
4 Technology 12.81%
5 Financials 12.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HSKA
476
DELISTED
Heska Corp
HSKA
– –
-5,700
Closed -$592K
LPNT
477
DELISTED
LifePoint Health, Inc.
LPNT
– –
-7,124
Closed -$348K
16 17 18 19
20

Similar funds

RCG
Regatta Capital Group El Segundo, California $661M AUM 17.85% 1-Year Est. Return
FM
Freemont Management Vaud, Switzerland $661M AUM 60.48% 1-Year Est. Return
ACM
Arosa Capital Management Miami Beach, Florida $660M AUM 210.26% 1-Year Est. Return
UCMOK
United Capital Management of KS Salina, Kansas $660M AUM 50.85% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
FAM
Fulcrum Asset Management London, United Kingdom $662M AUM 48.09% 1-Year Est. Return
CAM
Chandler Asset Management San Diego, California $659M AUM 11.68% 1-Year Est. Return
AWA
Artemis Wealth Advisors New York $662M AUM 39.67% 1-Year Est. Return

Globeflex Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Globeflex Capital held 477 positions worth $509M, up 3.8% from $490M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Globeflex Capital's Q3 2018 filing shows 52 new, 137 increased, 129 reduced and 42 closed positions. Its largest new stake was Taro Pharmaceutical Industries Ltd.: 72,459 shares worth $7.12M. The largest sale was Acadian Asset Management, an estimated $7.07M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Globeflex Capital's largest Q3 2018 buy was Taro Pharmaceutical Industries Ltd.: 72,459 shares worth $7.12M.
  • Globeflex Capital added most to ICU Medical in Q3 2018, an estimated $1.85M increase.
  • Globeflex Capital's biggest Q3 2018 reduction was Acadian Asset Management, cutting an estimated $7.07M.
  • Globeflex Capital fully exited KMG Chemicals Inc in Q3 2018, selling an estimated $4.5M.
  • Globeflex Capital's ten largest holdings make up 15% of its $509M portfolio in Q3 2018.
  • Globeflex Capital opened 52 new positions and closed 42 in Q3 2018.
  • Globeflex Capital's portfolio value rose 3.8% quarter-over-quarter to $509M.

Based on Globeflex Capital's 13F filing for Q3 2018, filed 9 Nov 2018.